Hydroxy‐Safflower Yellow A Inhibits Breast Cancer Growth via Tumor‐Associated Macrophages/ CCL5 /Tissue Resident Memory T Cell Signaling
BioFactors · 2026-03 · 52 (2)
DOI: 10.1002/biof.70096 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 16.04.2026. Verfasst von Le Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, the …. Hauptthemen laut MEDLINE: Chemokine CCL5, Tumor-Associated Macrophages, Breast Neoplasms, Memory T Cells. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Dongguan Science and Technology of Social Development Program, National Natural Science Foundation Cultivation Project of Dongguan People's Hospital.
Abstract (Originalsprache)
Hydroxy‐safflor yellow A (HSYA), a bioactive compound from Carthamus tinctorius , has reported anti‐inflammatory and antitumor activities. However, its effects on breast cancer and the underlying immune mechanisms remain poorly defined. In this study, we investigated the immunomodulatory role of HSYA in breast cancer, with a focus on its impact on tumor‐associated macrophages (TAMs) and T cell responses. Using in vitro assays, murine breast cancer models, and single‐cell transcriptomic analysis, we found that HSYA significantly inhibited tumor growth and reshaped the tumor immune microenvironment. Flow cytometry and transcriptomic profiling revealed that HSYA treatment reduced tumor‐associated macrophages (TAMs) infiltration and suppressed C‐C motif chemokine ligand 5 (CCL5) expression, which was associated with enhanced recruitment and activation of tissue‐resident memory T (TRM) cells. Co‐culture and functional assays further supported a role for the TAM/CCL5 axis in mediating these immune effects. Collectively, our findings demonstrate that HSYA exerts antitumor activity, at least in part, by modulating the TAM/CCL5/TRM axis, highlighting its potential as an immunomodulatory therapeutic strategy in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, the Tenth Affiliated Hospital, Southern Medical University (Dongguan Peopl…
- Department of General Medicine, Dongguan Daojiao Hospital, Dongguan, Guangdong, China.
- Shenzhen School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.
- Department of Breast Surgery, the Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, China.
- Department of Pharmacy, the Tenth Affiliated Hospital, Southern Medical University (Donggaun People's Hospital), Dongguan, Guangdong, China.
- Department of Pathology, the Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, China.
ORCID-Profile: Le Zhou, Linxuan Huang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Dongguan Science and Technology of Social Development Program
- National Natural Science Foundation Cultivation Project of Dongguan People's Hospital
Zitieren
APA
Zhou, L., Lai, G., Han, B., Yuan, Y., Dong, Z., Shi, Y., Yuan, H., He, G., Huang, L., Xie, B., Liao, Y., Pan, X., Liu, C., Yao, B., & Zheng, R. (2026). Hydroxy‐Safflower Yellow A Inhibits Breast Cancer Growth via Tumor‐Associated Macrophages/ CCL5 /Tissue Resident Memory T Cell Signaling. BioFactors, 52(2). https://doi.org/10.1002/biof.70096
Vancouver
Zhou L, Lai G, Han B, Yuan Y, Dong Z, Shi Y, et al. Hydroxy‐Safflower Yellow A Inhibits Breast Cancer Growth via Tumor‐Associated Macrophages/ CCL5 /Tissue Resident Memory T Cell Signaling. BioFactors. 2026;52(2). doi:10.1002/biof.70096
BibTeX
@article{Zhou2026,
author = {Zhou, Le and Lai, Guowei and Han, Bo and Yuan, Yinjiao and Dong, Zhuowei and Shi, Yijing and Yuan, Huiling and He, Guangning and Huang, Linxuan and Xie, Baocheng and Liao, Yuting and Pan, Xuebing and Liu, Caixiang and Yao, Biao and Zheng, Ruinian},
title = {Hydroxy‐Safflower Yellow A Inhibits Breast Cancer Growth via Tumor‐Associated Macrophages/ CCL5 /Tissue Resident Memory T Cell Signaling},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {2},
doi = {10.1002/biof.70096}
}
EUVIMED